FibroGen, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 378.00 K | $4.63 M | 12.50% | 9.35% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 235.30 K | $2.88 M | -13.94% | 5.82% |
| VANGUARD GROUP INC | 11/07/2025 | 184.24 K | $2.26 M | 3.48% | 4.56% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 110.28 K | $1.35 M | -20.73% | 2.73% |
| BLACKROCK, INC. | 11/12/2025 | 84.75 K | $1.04 M | 0.00% | 2.10% |
| MARSHALL WACE, LLP | 11/13/2025 | 72.45 K | $887.50 K | 0.21% | 1.79% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/12/2025 | 58.88 K | $721.27 K | -34.36% | 1.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 47.10 K | $576.98 K | -15.14% | 1.17% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 43.68 K | $535.23 K | -0.80% | 1.08% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 40.22 K | $492.67 K | 185.01% | 1.00% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 39.75 K | $486.89 K | 0.00% | 0.98% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 29.28 K | $358.69 K | 161.88% | 0.72% |
| CITADEL ADVISORS LLC | 11/14/2025 | 23.52 K | $288.08 K | 100.00% | 0.58% |
| STATE STREET CORP | 11/14/2025 | 20.28 K | $248.48 K | 47.85% | 0.50% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 16.37 K | $200.53 K | 100.00% | 0.41% |
| WOLVERINE TRADING, LLC | 11/14/2025 | 11.60 K | $142.85 K | 9.43% | 0.29% |
| DRW SECURITIES, LLC | 11/14/2025 | 11.22 K | $137.38 K | 100.00% | 0.28% |
| UBS GROUP AG | 11/13/2025 | 8.67 K | $106.17 K | -15.75% | 0.21% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 4.63 K | $56.69 K | -35.80% | 0.11% |
| CITIGROUP INC | 11/10/2025 | 2.17 K | $26.56 K | 100.00% | 0.05% |
| MORGAN STANLEY | 11/14/2025 | 1.55 K | $18.94 K | -6.87% | 0.04% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 642 | $7.86 K | 0.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 595 | $7.29 K | 34.31% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 288 | $3.53 K | -63.68% | 0.01% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/24/2025 | 287 | $3.52 K | 0.00% | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 11/14/2025 | 193 | $2.32 K | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 152 | $1.86 K | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 137 | $2.00 K | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 49 | $600 | 2.08% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 40 | $490 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 12 | $147 | 0.00% | 0.00% |
| US BANCORP \DE\ | 11/12/2025 | 1 | $12 | 0.00% | 0.00% |
| DANSKE BANK A/S | 11/19/2025 | 1 | $12 | 100.00% | 0.00% |
| CONNECTIVE CAPITAL MANAGEMENT, LLC | 11/17/2025 | 0 | $0 | -100.00% | 0.00% |
| GFG CAPITAL, LLC | 10/07/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
FibroGen, Inc. institutional Ownership - FAQ's
During the previous two years, 88 institutional investors and hedge funds held shares of FibroGen, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 378,000
VANGUARD GROUP INC: 184,244
ACADIAN ASSET MANAGEMENT LLC: 110,281
BlackRock, Inc.: 84,751
MARSHALL WACE, LLP: 72,449
PRIMECAP MANAGEMENT CO/CA/: 58,879
28.01% of FibroGen, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 12.80 M shares in the last 24 months. This purchase volume represents approximately $150.13 M in transactions.